Here’s Why Dexcom (DXCM) Traded Down in Q3
Sands Capital, an investment management company, released its “Sands Capital Select Growth Strategy” Q3 2025 investor letter. A copy of the letter can be downloaded here. U.S.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 6,778,490 | $456,124,592 | +396% | 0.07% |
| 2. | 259,028,000 | $257,311,473 | +10% | 0.86% | |
| 3. | Millennium Management Israel Englander | 3,431,265 | $230,889,822 | +1266% | 0.1% |
| 4. | Holocene Advisors Brandon Haley | 2,436,672 | $163,963,659 | 0.37% | |
| 5. | Point72 Asset Management Steve Cohen | 2,235,987 | $150,459,504 | 0.25% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.43 | 2,500 | $138,563.00 | 331,697 | 2025-11-10 | Filing | |
| $54.98 | 15,700 | $863,138.90 | 329,197 | 2025-11-10 | Filing | |
| $50.01 | 25,000 | $1,250,250.00 | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | $496,100.00 | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | $1,085,000.00 | 121,975 | 2013-03-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $59.05 | 2,906 | $171,599.30 | 35,088 | 2025-11-14 | Filing | |
| $58.07 | 1,012 | $58,766.84 | 27,031 | 2025-11-12 | Filing | |
| $55.17 | 3,948 | $217,811.16 | 37,994 | 2025-11-10 | Filing | |
| $80.86 | 667 | $53,933.62 | 22,667 | 2025-09-05 | Filing | |
| $80.00 | 1,466 | $117,280.00 | 105,223 | 2025-09-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 49,456,043 | $3,327,897,134 | 0.05% | |
| 2. | 38,821,843 | $2,612,321,824 | 0.05% | |
| 3. | 16,855,113 | $1,134,180,554 | 0.04% | |
| 4. | 15,882,168 | $1,068,711,084 | 0.79% | |
| 5. | 10,963,772 | $734,939,750 | 0.05% |
News See All
Morgan Stanley, Truist Cautious on DexCom (DXCM) Cites Weaker Gross Margins, Modest Q3 Beat
DexCom Inc. (NASDAQ:DXCM) is one of the best QQQ stocks to buy according to Wall Street analysts.
Carillon Eagle Mid Cap Growth Fund’s Views on Dexcom (DXCM)
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
12 Best QQQ Stocks to Buy According to Wall Street Analysts
On November 24, Scott Chronert, Citi US equity strategist, joined CNBC's 'Squawk on the Street' to discuss where the market stands heading into the end of the year.
Aristotle Atlantic’s Core Equity Strategy Initiated a Position in Dexcom (DXCM) Backed by Its Robust Financial Stability
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor letter. The letter highlighted the market review, quarterly performance, and...
DexCom, Inc. (NASDAQ:DXCM) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the DexCom Third Quarter 2025 Earnings Release Conference Call. My name is Abby, and I will be your operator for today's call.
Truist Lowers DexCom (DXCM) PT to $94 Ahead of Q3 MedTech Sector Preview, Maintains Buy Rating
DexCom Inc. (NASDAQ:DXCM) is one of the best NASDAQ growth stocks to buy for the next 5 years.
10 Best NASDAQ Growth Stocks to Buy for the Next 5 Years
On October 24, Peter Oppenheimer, Chief Global Equity Strategist at Goldman Sachs, appeared on CNBC to suggest that the tech rally is grounded in fundamentals, not speculation, though rising excitement...
DexCom, Inc. (DXCM): A Bear Case Theory
We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on DXCM.
Here’s Why Artisan Mid Cap Fund Exited Dexcom (DXCM)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.